Evidence map›Paper›PMID 42306487›Full record

ArticleInternational journal of women's health2026

Decreased CD8+ T Lymphocytes is an Independent Influencing Factor for Persistent HR-HPV Infection.

MeiXiu Huang, HuiFang Lei, YanHua Lin, WeiWei Li, JianFeng Guo, QingYu Liu, LanLan Chen, Fang Xie, XiuQing Weng, YaFang Kang and 2 more

Abstract read
In one paragraph

Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

MeiXiu Huang *Department of Gynecology, Ningde Mindong Hospital, Fujian Medical University, Fuan, People's Republic of China.
HuiFang Lei *Department of Gynecology, Ningde Mindong Hospital, Fujian Medical University, Fuan, People's Republic of China.ORCID 0000-0001-8361-6799
YanHua LinDepartment of Gynecology, Ningde Mindong Hospital, Fujian Medical University, Fuan, People's Republic of China.
WeiWei LiDepartment of Gynecology, Ningde Mindong Hospital, Fujian Medical University, Fuan, People's Republic of China.
JianFeng GuoDepartment of Laboratory, Ningde Mindong Hospital, Fujian Medical University, Fuan, People's Republic of China.
QingYu LiuDepartment of Gynecology, Ningde Mindong Hospital, Fujian Medical University, Fuan, People's Republic of China.
LanLan ChenDepartment of Gynecology, Ningde Mindong Hospital, Fujian Medical University, Fuan, People's Republic of China.
Fang XieDepartment of Gynecology, Ningde Mindong Hospital, Fujian Medical University, Fuan, People's Republic of China.
XiuQing WengDepartment of Pathology, Ningde Mindong Hospital, Fujian Medical University, Fuan, People's Republic of China.
YaFang KangLaboratory of Gynecologic Oncology, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fuzhou, People's Republic of China.ORCID 0000-0002-7987-7280
HanFeng LinDepartment of Obstetrics, Ningde Mindong Hospital, Fujian Medical University, Fuan, People's Republic of China.
PengMing SunLaboratory of Gynecologic Oncology, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fuzhou, People's Republic of China.ORCID 0000-0002-5072-6091

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To explore the characteristics of vaginal microecological changes and peripheral blood immune cell subset levels in patients with high-risk human papillomavirus (HR-HPV) infection, and to identify independent risk factors for persistent HR-HPV infection, so as to provide a reference for clinical prevention and treatment of cervical lesions. Methods: A total of 165 participants admitted to Ningde Mindong Hospital from January 2021 to December 2022 were enrolled in this single-center observational study, including 49 cases with persistent HR-HPV positivity and 116 cases with transient HR-HPV infection. Vaginal microecological indicators (cleanliness, pH, bacterial vaginosis score, hydrogen peroxide, sialidase) and peripheral blood immune cell subsets were detected to analyse. Results: Compared with the transient HR-HPV infection group, the persistent infection group showed significant vaginal microecological imbalance, including lower proportion of grade I-II vaginal cleanliness, higher BV score ≥4, lower proportion of pH ≤4.5, and higher positive rates of hydrogen peroxide and sialidase (all P<0.05). In addition, in the present study, sialidase was also significantly increased in the group with cytological and pathological results ≥HSIL (P<0.05). The percentages of CD4+ T lymphocytes and CD8+ T lymphocytes in the persistent infection group were significantly decreased (P<0.05), while there were no significant differences in T lymphocytes, B lymphocytes, and NK cells between the two groups (P>0.05). Multivariate Logistic regression analysis showed that decreased CD8+ T lymphocytes was an independent risk factor for persistent HR-HPV infection (P<0.05). Conclusion: Persistent HR-HPV infection is closely associated with vaginal microecological imbalance and impaired cellular immune function. This exploratory study confirms that decreased CD8+ T lymphocytes is independently associated with persistent HR-HPV infection. Comprehensive assessment of vaginal microecological status and CD8+ T lymphocyte level may help identify high-risk populations, but the clinical predictive value needs to be verified by large-sample prospective studies.

Indexed as

high risk human papillomaviruslymphocytesvaginal microbiota

Identifiers

PMID42306487
PMCPMC13267810

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.